Virtual Ward for Early Discharge in Patients Receiving Inpatient Care
VIP care
1 other identifier
interventional
306
1 country
1
Brief Summary
This study evaluates the feasibility of providing hospital-level care at home for eligible patients through a Virtual Ward. Patients are discharged early from the hospital and monitored remotely using digital vital sign monitoring and anamnesis questionnaires. The primary aim is to determine if at least 30% of eligible patients can be safely and successfully transferred to the Virtual Ward under current Dutch healthcare conditions.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Apr 2025
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 13, 2025
CompletedStudy Start
First participant enrolled
April 16, 2025
CompletedFirst Posted
Study publicly available on registry
April 20, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 16, 2028
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 31, 2028
February 17, 2026
February 1, 2026
3.5 years
April 13, 2025
February 15, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Number of Participants Successfully Transferred to the Virtual Ward After Providing Informed Consent
Successful transfer is defined as discharge from hospital to the Virtual Ward with start of home monitoring according to care pathways. Threshold for feasibility is ≥30%.
From enrollment to transfer to Virtual Ward (during hospitalization, up to 7 days)
Secondary Outcomes (10)
Number of Eligible Patients Invited for Participation
From enrollment to invitation during hospitalization (up to 7 days)
Number of Invited Patients Providing Informed Consent
From enrollment to signing informed consent during hospitalization (up to 7 days)
Time from Study Inclusion to Transfer to Virtual Ward
From informed consent to Virtual Ward admission (up to 7 days)
Number of Notifications Generated During Virtual Ward Monitoring
From Virtual Ward admission up to 30 days after discharge
Number of Contact Moments with Virtual Ward Staff
From Virtual Ward admission up to 30 days after discharge
- +5 more secondary outcomes
Other Outcomes (3)
Frailty Status Based on Clinical Frailty Scale and PRISMA-7 Questionnaire
At enrollment (baseline)
Patient-Reported Experience of Virtual Ward Care
Within 30 days after Virtual Ward discharge
Healthcare Provider-Reported Experience of Virtual Ward Care
Approximately 6-12 months after study initiation
Study Arms (1)
Virtual Ward arm
EXPERIMENTALPatients receive hospital-level care at home via a Virtual Ward, including remote monitoring of vital signs, digital anamnesis questionnaires, and standard diagnostics and treatment, supported by telemonitoring staff and hospital physicians.
Interventions
Hospital-level care at home using remote vital sign monitoring, digital anamnesis via the Digizorg app, and integration with the Electronic Medical Record (HiX), managed by Virtual Ward staff following predefined care pathways.
Eligibility Criteria
You may qualify if:
- Adult patients (≥18 years old).
- Currently hospitalized and eligible for early discharge according to clinical judgment.
- Ability to provide written informed consent.
- Access to a smartphone or tablet with internet connection.
- Patient is capable of using the Digizorg app or has support from a caregiver who can assist.
- Suitable home situation for Virtual Ward care (e.g., safe environment, necessary utilities available).
- Enrollment in one of the predefined Virtual Ward care pathways
You may not qualify if:
- Patients requiring continuous hospital-based monitoring or interventions that cannot be safely delivered at home.
- Patients who are hemodynamically unstable or require oxygen therapy \>5 liters/minute at the time of discharge.
- Patients unable or unwilling to comply with home monitoring procedures.
- Patients with significant cognitive impairment without adequate caregiver support.
- Patients with a life expectancy less than 30 days, as assessed by the treating physician.
- Patients participating in another interventional clinical trial that could interfere with the Virtual Ward protocol.
- Any other condition that, in the opinion of the treating physician, would make participation unsafe or infeasible.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Erasmus Medical Center
Rotterdam, Netherlands
Related Publications (1)
van Herwerden MC, Scholte NTB, Mkrtchjan A, Feyz L, Mol AP, Aitken J, de Boer RA, Chandoesing PP, Gommers DAMPJ, De Haan B, Den Hoed CM, van den Hoogen MWF, Peeters RP, Wlazlo N, Van Der Boon RMA, van De Weg CAM. Delivering hospital care at home in a Dutch Tertiary University Hospital: protocol for a prospective feasibility cohort study evaluating a Virtual Ward for early discharge of inpatients. BMJ Open. 2026 Feb 24;16(2):e115730. doi: 10.1136/bmjopen-2025-115730.
PMID: 41734918DERIVED
Study Officials
- PRINCIPAL INVESTIGATOR
Cox van de Weg, MD, PhD
Erasmus Medical Center
Central Study Contacts
Cox van de Weg, MD, PhD
CONTACT
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- HEALTH SERVICES RESEARCH
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
April 13, 2025
First Posted
April 20, 2025
Study Start
April 16, 2025
Primary Completion (Estimated)
October 16, 2028
Study Completion (Estimated)
December 31, 2028
Last Updated
February 17, 2026
Record last verified: 2026-02